Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 227 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Integrated Treatment Clear all

Conditions: Schizophrenia, Major Depressive Disorder, Bipolar I Disorder
Interventions: Aripiprazole + IEM (Ingestible Event Marker); Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 4
States / cities: Granada Hills, California • Rochester, New York • Durham, North Carolina + 1 more

Conditions: Type2 Diabetes
Interventions: BT-001; Device
Lead sponsor: Better Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Smoking Cessation
Interventions: BTSCS; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 75 Years
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 3
States / cities: Baltimore, Maryland • Timonium, Maryland

Conditions: Age Related Macular Degeneration, Diabetic Retinopathy, Glaucoma
Interventions: Text Message Reminder, Health Worker Visit; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Spasticity
Interventions: Corabotase, Placebo, Dysport; Biological · Drug
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 5
States / cities: Downey, California • Overland Park, Kansas • Farmington Hills, Michigan + 2 more

Conditions: Substance Abuse, Traumatic Stress
Interventions: Trauma-focused Substance Abuse Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 13 Years to 19 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Adenocarcinoma of Lung, Lung Neoplasm, Cancer of Lung, Lung Cancer, Pulmonary Cancer, EGFR Genes, ALK Genes
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alcohol Use Disorder
Interventions: Mobile health application, Medical Management; Other
Lead sponsor: Quit Genius; Industry
Eligibility: 18 Years and older
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ, Carcinoma in Situ Concurrent With Papillary Tumors
Interventions: CG0070 Adenovirus Vector, Control Arm: Quadruple Choice; Biological · Other
Lead sponsor: CG Oncology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 7
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 4 more

Conditions: Healthy
Interventions: High Hydrostatic Pressure Processing; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Depression, Obesity
Interventions: RAINBOW Intervention Program; Behavioral
Lead sponsor: Palo Alto Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 409 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Pancreatic Cancer
Interventions: dexamethasone, fluorouracil, brachytherapy, phosphorus P32, radiation therapy; Drug · Radiation
Lead sponsor: Center for Molecular Medicine; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2007
U.S. locations: 2
States / cities: Atlanta, Georgia • Garden City, New York

Conditions: Electronic Health Records
Interventions: Integrated Medication Manager; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Stroke
Interventions: CARE-CITE Gait; Behavioral
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Lung Cancer
Interventions: Onartuzumab, Erlotinib, Paclitaxel, Carboplatin, Radiation Therapy; Drug · Radiation
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Depression, Attention Deficit Disorder With Hyperactivity
Interventions: Integrated Parent Training, Behavioral Parent Training; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 6 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: College Park, Maryland

Conditions: Mental Health Issue, Hiv, Substance Use
Interventions: Single Session Narrative Therapy; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetes Mellitus, Type 1
Interventions: Usual care, Collaborative care model (CoCM); Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Substance Abuse
Interventions: Patient-administered screening tool, Patient health navigator-administered screening tool, Patient health navigator-assisted linkage to treatment; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 3,358 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Substance Use Disorder, Opioid Use Disorder, Adolescent
Interventions: Integrated Behavioral Health System with SUD Resources; Other
Lead sponsor: Indiana University; Other
Eligibility: 12 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Autism Spectrum Disorder
Interventions: Oxytocin, Social Cognitive Skills Training, Facilitated Play Therapy; Drug · Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 8 Years to 11 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brain Metastases
Interventions: Cohort A, Cohort B; Radiation
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 3
States / cities: Indianapolis, Indiana

Conditions: Moderate-severe Chronic Kidney Disease Not Treated With Dialysis, Diabetic Kidney Disease, HgbA1c Less Than 8.5
Interventions: Combined Aerobic and Resistance Exercise via videoconferencing; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 30 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Opiate Dependence, HIV Infections
Interventions: Integrating drug treatment into HIV services; Behavioral
Lead sponsor: Organization to Achieve Solutions in Substance Abuse (OASIS); Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 3
States / cities: Oakland, California • San Leandro, California

Search by objective public record fields.

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)

Strategies for Improving Linkage-to-Care After Eye Disease Screening

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Integrated Digital Intervention for Alcohol Use Disorder

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study

Research Aimed at Improving Both Mood and Weight

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

VA Integrated Medication Manager

Carepartner Collaborative Integrated Therapy Gait (CARE-CITE-Gait) Program

Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)

Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder

Walk-in Therapy in Low Barrier Primary Care

Testing an Integrated Care Model Trial

Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings

Workforce and System Change to Treat Adolescent Opioid Use Disorder Within Integrated Pediatric Primary Care

Oxytocin and Social Cognitive Skills Groups

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKD

Integrating Buprenorphine Into HIV Treatment